Infectious Diseases and Antimicrobial Therapy
Research activity includes acute bacterial prostatitis caused by multidrug-resistant Escherichia coli, with interest in oral fosfomycin-trometamol and other antibiotic treatment options for resistant urinary tract infections.
- Multidrug-resistant E. coli
- Acute bacterial prostatitis
- Oral fosfomycin
The sponsor’s infectious disease portfolio is centered on bacterial prostatitis and the management of antimicrobial resistance in urological infection.
Cardiology and Heart Failure
Clinical interest extends to patients hospitalized with acute decompensated heart failure, particularly those experiencing refractory dyspnoea and requiring symptom-focused supportive care.
- Acute decompensated heart failure
- Refractory dyspnoea
- Hospital-based supportive care
This area reflects involvement in the symptomatic treatment of advanced cardiac disease in an inpatient setting.
Palliative Care and Symptom Relief
The sponsor studies opioid-based analgesia and relief of severe breathlessness, with attention to the comparative use of fentanyl and morphine in palliative symptom control.
- Fentanyl
- Morphine
- Refractory dyspnoea
Research in this field focuses on comfort-oriented treatment for patients with serious cardiorespiratory illness.
